Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose Tissue
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Mesenchymal stem cells (MSCs) represent a promising tool for new clinical concepts in supporting cellular therapy. Bone marrow (BM) was the first source reported to contain MSCs. However, for clinical use, BM may be detrimental due to the highly invasive donation procedure and the decline in MSC number and differentiation potential with increasing age. More recently, umbilical cord blood (UCB), attainable by a less invasive method, was introduced as an alternative source for MSCs. Another promising source is adipose tissue (AT). We compared MSCs derived from these sources regarding morphology, the success rate of isolating MSCs, colony frequency, expansion potential, multiple differentiation capacity, and immune phenotype. No significant differences concerning the morphology and immune phenotype of the MSCs derived from these sources were obvious. Differences could be observed concerning the success rate of isolating MSCs, which was 100% for BM and AT, but only 63% for UCB. The colony frequency was lowest in UCB, whereas it was highest in AT. However, UCB-MSCs could be cultured longest and showed the highest proliferation capacity, whereas BM-MSCs possessed the shortest culture period and the lowest proliferation capacity. Most strikingly, UCB-MSCs showed no adipogenic differentiation capacity, in contrast to BM- and AT-MSCs. Both UCB and AT are attractive alternatives to BM in isolating MSC: AT as it contains MSCs at the highest frequency and UCB as it seems to be expandable to higher numbers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As plating density can affect proliferation kinetics of MSCs [16, 23], cells from all tissue sources were grown for at least two passages under two seeding densities: 300 and 3000 cells/cm2.”
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Human Adipose Tissue Is a Source of Multipotent Stem Cells
Zuk, P. A., Zhu, M., Ashjian, P., De Ugarte, D. A., Huang, J. I., Mizuno, H., Alfonso, Z. C., Fraser, J. K., Benhaim, P., & Hedrick, M. H. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-02-0105 · Cited by 6,664
Caplan, A. I. (1991) · Journal of Orthopaedic Research · doi:10.1002/jor.1100090504 · Cited by 6,548
Le Blanc, K., Rasmusson, I., Sundberg, B., Götherström, C., Hassan, M., Uzunel, M., & Ringdén, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16104-7 · Cited by 2,734
Horwitz, E. M., Gordon, P. L., Koo, W. K. K., Marx, J. C., Neel, M. D., McNall, R. Y., Muul, L., & Hofmann, T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132252399 · Cited by 1,650
Mesenchymal progenitor cells in human umbilical cord blood
Erices, A., Conget, P., & Minguell, J. J. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.01986.x · Cited by 1,613
Isolation of multipotent mesenchymal stem cells from umbilical cord blood
Lee, O. K., Kuo, T. K., Chen, W.-M., Lee, K.-D., Hsieh, S.-L., & Chen, T.-H. (2004) · Blood · doi:10.1182/blood-2003-05-1670 · Cited by 1,360
Wagner, W., Wein, F., Seckinger, A., Frankhauser, M., Wirkner, U., Krause, U., Blake, J., Schwager, C., Eckstein, V., Ansorge, W., et al. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2005.07.003 · Cited by 1,259
Stenderup, K. (2003) · Bone · doi:10.1016/j.bone.2003.07.005 · Cited by 1,206
Kögler, G., Sensken, S., Airey, J. A., Trapp, T., Müschen, M., Feldhahn, N., Liedtke, S., Sorg, R. V., Fischer, J., Rosenbaum, C., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040440 · Cited by 1,029
Research works printed but not linked: 1
- 10.1210/endo.134.1.8275945 · doi:10.1210/endo.134.1.8275945 · Paper page
Cited by
Items 501–600 of 1,013
Scalable microcarrier-based manufacturing of mesenchymal stem/stromal cells
de Soure, A. M., Fernandes‐Platzgummer, A., da Silva, C. L., & Cabral, J. M. S. (2016) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2016.08.007 · Cited by 96
“…BM (Castro-Malaspina et al., 1980; Friedenstein et al., 1970), MSC can also be isolated from other adult sources such as the adipose tissue (AT) (Kern et al., 2006), dental pulp (Pierdomenico et al., 2005) and synovial membrane (SM) (De Bari et al., 2001a; Santhagunam et al., 2014), as well as…”
BackgroundSicari, B. M., Dearth, C. L., & Badylak, S. F. (2013) · The Anatomical Record · doi:10.1002/ar.22794 · Cited by 97
“For example, following injection into injured skeletal muscle, ADSCs modulate inflammation, increase angiogenesis, and restore dystrophin expression in mouse models of muscular dystrophy (Pinheiro et al., 2012).”
BackgroundInfluentialMesenchymal Stromal Cells Affect Disease Outcomes via Macrophage Polarization
Zheng, G., Ge, M., Qiu, G., Shu, Q., & Xu, J. (2015) · Stem Cells International · doi:10.1155/2015/989473 · Cited by 83
“However, there were reported variations in colony frequency and proliferation capacity for MSCs among the three sources [32].”
BackgroundMistriotis, P., & Andreadis, S. T. (2013) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2012.0422 · Cited by 86
Mesenchymal Stem Cells Beyond Regenerative Medicine
Shammaa, R., El-Kadiry, A. E.-H., Abusarah, J., & Rafei, M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00072 · Cited by 93
“…on MSC lineages have also identified distinctive molecular (Al-Nbaheen et al., 2013; Ullah et al., 2015; Wu et al., 2018), proliferation/differentiation (Kern et al., 2006), and functional properties (Keyser et al., 2007), accrediting the fact that their biology is still partially intelligible.”
BackgroundStem cell strategies in burns care
Burd, A. R., Ahmed, K., Lam, S., Ayyappan, T., & Huang, L. (2007) · Burns · doi:10.1016/j.burns.2006.08.031 · Cited by 94
“from cosmetic liposuction [57].”
BackgroundMarino, G., Rosso, F., Cafiero, G., Tortora, C., Moraci, M., Barbarisi, M., & Barbarisi, A. (2009) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-009-3840-z · Cited by 88
“[4]. Fibroblast-like adipose tissue-derived mesenchymal stem cells (ADSC-FL) are morphologically similar to hMSCs obtained from other tissues by isolation and culturing [ 2 ].”
BackgroundShetty, P., Cooper, K., & Viswanathan, C. (2010) · Asian Journal of Transfusion Science · doi:10.4103/0973-6247.59386 · Cited by 88
Optimal Timing of Mesenchymal Stem Cell Therapy for Neonatal Intraventricular Hemorrhage
Park, W. S., Sung, S. I., Ahn, S. Y., Sung, D. K., Im, G. H., Yoo, H. S., Choi, S. J., & Chang, Y. S. (2016) · Cell Transplantation · doi:10.3727/096368915x689640 · Cited by 88
Kim, H. K., Lee, S., Lee, S., Oh, B. J., Kim, J. H., Kim, J. A., Lee, G., Jang, J.-D., & Joe, Y. A. (2018) · Stem Cells · doi:10.1002/stem.2920 · Cited by 95
Mesenchymal Stromal Cells for Graft Versus Host Disease: Mechanism-Based Biomarkers
Cheung, T. S., Bertolino, G. M., Giacomini, C., Bornhäuser, M., Dazzi, F., & Galleu, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01338 · Cited by 89
“Third, they have higher proliferative capacity and longer life-span in vitro with higher cells yielded per expansion (94, 95).”
BackgroundEmerging delivery approaches for targeted pulmonary fibrosis treatment
Diwan, R., Bhatt, H., Beaven, E., & Nurunnabi, M. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115147 · Cited by 89
Potential of mesenchymal stem cells as immune therapy in solid-organ transplantation
Crop, M., Baan, C., Weimar, W., & Hoogduijn, M. (2009) · Transplant International · doi:10.1111/j.1432-2277.2008.00786.x · Cited by 86
Liu, J., Chen, J., Liu, B., Yang, C., Xie, D., Zheng, X., Xu, S., Chen, T., Wang, L., Zhang, Z., et al. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.11.022 · Cited by 90
Human salivary gland stem cells ameliorate hyposalivation of radiation-damaged rat salivary glands
Jeong, J., Baek, H., Kim, Y. J., Choi, Y.-W., Lee, H., Lee, E. J., Kim, E. S., Hah, J. H., Kwon, T., Choi, I. J., et al. (2013) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.121 · Cited by 86
Semon, J. A., Zhang, X., Pandey, A. C., Alandete, S. M., Maness, C., Zhang, S., Scruggs, B. A., Strong, A. L., Sharkey, S. A., Beuttler, M. M., et al. (2013) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0032 · Cited by 86
Células-tronco derivadas de tecido adiposo humano: desafios atuais e perspectivas clínicas
Yarak, S., & Okamoto, O. K. (2010) · Anais Brasileiros de Dermatologia · doi:10.1590/s0365-05962010000500008 · Cited by 133
Strategies for regeneration of the bone using porcine adult adipose-derived mesenchymal stem cells
Monaco, E. L., Bionaz, M., Hollister, S. J., & Wheeler, M. B. (2011) · Theriogenology · doi:10.1016/j.theriogenology.2010.11.020 · Cited by 92
Kim, D.-S., Kim, J. H., Kwon Lee, J., Choi, S. J., Kim, J.-S., Jeun, S.-S., Oh, W., Yang, Y. S., & Chang, J. W. (2009) · Stem Cells and Development · doi:10.1089/scd.2008.0050 · Cited by 85
“MSCs express CD24, CD49, CD90, CD105 and lacking CD14, CD45, and HLA-DR [3,4].”
Mesenchymal stromal cells multipotency and plasticity: induction toward the hepatic lineage.
Saulnier, N., Lattanzi, W., Puglisi, M. A., Pani, G., Barba, M., Piscaglia, A. C., Giachelia, M., Alfieri, S., Neri, G., Gasbarrini, G., et al. (2009) · PubMed · Cited by 100
Mesenchymal Stem Cells for Treating Articular Cartilage Defects and Osteoarthritis
Wang, Y., Yuan, M., Guo, Q., Lu, S., & Peng, J. C. (2014) · Cell Transplantation · doi:10.3727/096368914x683485 · Cited by 89
Agrawal, P., & Pramanik, K. (2016) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-016-9092-3 · Cited by 89
“The collection of UCB is non-invasive and less expensive procedure than collecting MSCs from other potential sources like BM aspirates [27] and adipose tissue [26].”
Hung, B. P., Hutton, D. L., Kozielski, K., Bishop, C. J., Naved, B. A., Green, J. J., Caplan, A. I., Gimble, J. M., Dorafshar, A. H., & Grayson, W. L. (2015) · Stem Cells · doi:10.1002/stem.2060 · Cited by 91
Mesenchymal stem cells: A new platform for targeting suicide genes in cancer
Tehrani, R. M., Verdi, J., Noureddini, M., Salehi, R., Salarinia, R., Mosallaei, M., Simonian, M., Alani, B., Ghiasi, M. R., Jaafari, M. R., et al. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26094 · Cited by 86
Bone defect healing is induced by collagen sponge/polyglycolic acid
Toosi, S. H., Naderi‐Meshkin, H., Kalalinia, F., Hosseinkhani, H., Heirani‐Tabasi, A., Havakhah, S., Nekooei, S., Jafarian, A. H., Rezaie, F., Peivandi, M. T., et al. (2019) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-019-6235-9 · Cited by 88
Requicha, J., Viegas, C. A., Albuquerque, C., de Azevedo, J. M. T., Reis, R. L., & Gomes, M. E. (2012) · Stem Cell Reviews and Reports · doi:10.1007/s12015-012-9397-0 · Cited by 101
Tang, Z., Xie, Y., Yang, F., Huang, Y., Wang, C., Dai, K., Zheng, X., & Zhang, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066263 · Cited by 93
Yoon, I., Chung, C., Sung, J.-H., Cho, H., Kim, J., Shim, W., Shim, C., Chung, S., & Kim, D. (2011) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2011.06.018 · Cited by 90
“1, AD-MSCs expressed CD73 (ecto-5-nucleoditase), CD90 (Thy-1), and CD105 (endoglin), but exhibited negligible expression of CD34 (sialomucin/haematopoietic progenitors).”
BackgroundInfluentialGao, F., Wu, D., Hu, Y., Jin, G., Li, G., Sun, T., & Li, F. (2008) · Translational research · doi:10.1016/j.trsl.2008.03.003 · Cited by 89
Sox2 Suppression by miR-21 Governs Human Mesenchymal Stem Cell Properties
Trohatou, O., Zagoura, D., Bitsika, V., Pappa, K. I., Antsaklis, A., Anagnou, N. P., & Roubelakis, M. G. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0081 · Cited by 84
Applications of neural and mesenchymal stem cells in the treatment of gliomas
Kosztowski, T. A., Zaidi, H. A., & Quiñones‐Hinojosa, A. (2009) · Expert Review of Anticancer Therapy · doi:10.1586/era.09.22 · Cited by 93
Hua, J., Gong, J. F., Meng, H., Xu, B., Yao, L., Qian, M., He, Z., Zou, S., Zhou, B. O., & Song, Z. (2013) · Cell Biology International · doi:10.1002/cbin.10188 · Cited by 86
“Since then, the focus has been on the success rate and optimisation of the isolation of MSCs from UCB (Bieback et al., 2004; Lee et al., 2004; Yang et al., 2004; Liu et al., 2007; Fan et al., 2009; Zhang et al., 2011; Sibov et al., 2012).”
BackgroundAnti-Inflammatory and Immunomodulatory Activities of Stem Cells
Peroni, J. F., & Borjesson, D. L. (2011) · Veterinary Clinics of North America Equine Practice · doi:10.1016/j.cveq.2011.06.003 · Cited by 93
Shi, X., Chen, Q., & Wang, F. W. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1336-4 · Cited by 90
Adipose tissue-derived stem cells in clinical applications
Pikuła, M., Marek-Trzonkowska, N. M., Wardowska, A., Renkielska, A., & Trzonkowski, P. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.823153 · Cited by 89
Barreca, M. M., Cancemi, P., & Geraci, F. (2020) · Cells · doi:10.3390/cells9051163 · Cited by 88
Wang, S., Hou, Y., Li, X., Song, Z., Sun, B., Li, X., & Zhang, H. (2020) · Aging · doi:10.18632/aging.103904 · Cited by 87
Isolation, Characterization, and Differentiation of Stem Cells for Cartilage Regeneration
Beane, O. S., & Darling, E. M. (2012) · Annals of Biomedical Engineering · doi:10.1007/s10439-012-0639-8 · Cited by 95
Bajpai, V. K., Mistriotis, P., & Andreadis, S. T. (2011) · Stem Cell Research · doi:10.1016/j.scr.2011.07.003 · Cited by 87
“…the differentiation potential of human MSCs from bone marrow, umbilical cord or adipose tissue decreasedwith time in culture (Wagner et al., 2008; Kern et al., 2006; Banfi et al., 2002; Kretlow et al., 2008), prompting us to determine the differentiation potential of hHF-MSCs as a function of…”
BackgroundA Review on the Effect of Plant Extract on Mesenchymal Stem Cell Proliferation and Differentiation
Saud, B., Malla, R., & Shrestha, K. (2019) · Stem Cells International · doi:10.1155/2019/7513404 · Cited by 90
Moroni, L., & Fornasari, P. M. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24223 · Cited by 79
“Careful analysis of potential genetic modifications due to extensive cell culture and expansion should be also carried to evaluate tumorogenesis, replicative aging, and loss of differentiation potential risks (Sekiya et al., 2002; Stolzing and Scutt, 2006; Wagner et al., 2010; Klopp et al., 2011).”
BackgroundPark, Y., Ha, C., Kim, J. A., Han, W., Rhim, J., Lee, H. J., Kim, K. J., Park, Y. G., & Chung, J. Y. (2016) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2016.10.012 · Cited by 83
Zhao, J., Yu, G., Cai, M., Lei, X., Yang, Y., Wang, Q., & Zhai, X. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0785-5 · Cited by 88
“[29], published in 2006, was the most cited article (1382 times) with an average citation of 115.”
Bone tissue engineering: Adult stem cells in combination with electrospun nanofibrous scaffolds
Moradi, S. L., Golchin, A., Hajishafieeha, Z., Khani, M., & Ardeshirylajimi, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26606 · Cited by 85
Lu, H., Wang, F., Mei, H., Wang, S., & Cheng, L. (2018) · Stem Cells International · doi:10.1155/2018/7537589 · Cited by 86
“compared the proliferative capacity of MSCs derived from adipose tissue, bone marrow, and umbilical cord blood and found that UCB-MSCs could be cultured longest and showed the highest proliferation capacity, whereas BMSCs possessed the shortest culture period and the lowest proliferation capacity [25].”
BackgroundLi, C.-J., Sun, L., & Pang, C. (2015) · Scientific Reports · doi:10.1038/srep09819 · Cited by 91
Balducci, L., Blasi, A., Saldarelli, M., Soleti, A., Pessina, A., Bonomi, A., Coccè, V., Dossena, M., Tosetti, V., Ceserani, V., et al. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt452 · Cited by 85
Sørensen, A. L., Jacobsen, B. M., Reiner, A. H., Andersen, I. S., & Collas, P. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-01-0018 · Cited by 81
“Multipotent cells isolated from adipose tissue, bone marrow, or skeletal muscle harbor mesenchymal stem cell (MSC) characteristics in vitro, such as plastic adherence, proliferation capacity, clonogenicity, immunophenotype, and ability to differentiate into several cell types (De Ugarte et al., 2003b; Delorme et al.,…”
BackgroundResultInfluentialMesenchymal stem cells for treating ocular surface diseases
Zhang, L., Coulson‐Thomas, V. J., Ferreira, T. G., & Kao, W. W. ‐. (2015) · BMC Ophthalmology · doi:10.1186/s12886-015-0138-4 · Cited by 87
Mesenchymal cells condensation-inducible mesh scaffolds for cartilage tissue engineering
Kim, I. G., Ko, J., Lee, H. R., Hee, S., & Park, K. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.01.048 · Cited by 83
Millán‐Rivero, J. E., Martínez, C. M., Romecín, P. A., Aznar‐Cervantes, S. D., Carpes, M., Cenís, J. L., Moraleda, J. M., Atuchá, N. M., & García‐Bernal, D. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1229-6 · Cited by 84
Schäfer, R., Bantleon, R., Kehlbach, R., Siegel, G., Wiskirchen, J., Wolburg, H., Kluba, T., Eibofner, F., Northoff, H., Claussen, C. D., et al. (2010) · BMC Cell Biology · doi:10.1186/1471-2121-11-22 · Cited by 82
“The MSCs were treated for 21 days with adipogenic medium, osteogenic medium or normal medium (control) as described previously [39,40] (modification: No addition of Amphotericin B): Adipogenic medium contained DMEM + 20% FCS with 1.”
Vascularization mediated by mesenchymal stem cells from bone marrow and adipose tissue: a comparison
Pill, K., Hofmann, S., Redl, H. R., & Holnthoner, W. (2015) · Cell Regeneration · doi:10.1186/s13619-015-0025-8 · Cited by 89
Lynch, K., & Pei, M. (2014) · Organogenesis · doi:10.4161/15476278.2014.970089 · Cited by 80
“Further, BMSCs that were cultured on plastic for 6 passages and then moved to fetal DECM displayed a 2.2-fold higher cell count after 3 additional passages relative to BMSCs cultured on plastic throughout, suggesting that fetal DECM was able to rescue the aged phenotype of adult BMSCs.47 Taken together, these studies…”
BackgroundInfluentialStubbendorff, M., Deuse, T., Hua, X., Phan, T. T., Bieback, K., Atkinson, K., EIERMANN, T. H., Velden, J., Schröder, C., Reichenspurner, H. C., et al. (2013) · Stem Cells and Development · doi:10.1089/scd.2013.0043 · Cited by 86
“In accordance with previous studies CB-MSC [27] and P-MSC [20] did not readily differentiate into cells of the adipogenic lineage.”
Self-citationZhou, Q., Ocampo, O. E. C., Guimarães, C. F., Kühn, P., van Kooten, T. G., & van Rijn, P. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b08237 · Cited by 85
Kargozar, S., Mozafari, M., Hamzehlou, S., Milan, P. B., Kim, H., & Baino, F. (2019) · Applied Sciences · doi:10.3390/app9010174 · Cited by 90
“compared UCB-MSCs with BM-MSCs and ASCs in terms of their morphology, the success rate of MSCs isolation, colony frequency, expansion potential, multiple differentiation capacities, and an immune phenotype [251].”
Musculoskeletal tissue engineering: Regional gene therapy for bone repair
Collon, K. W., Gallo, M. C., & Lieberman, J. R. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120901 · Cited by 90
Cord blood in regenerative medicine: do we need immune suppression?
Riordan, N. H., Chan, K. W. H., Marleau, A. M., & Ichim, T. E. (2007) · Journal of Translational Medicine · doi:10.1186/1479-5876-5-8 · Cited by 86
Prabakar, K. R., Domínguez‐Bendala, J., Molano, R. D., Pileggi, A., Villate, S., Ricordi, C., & Inverardi, L. (2012) · Cell Transplantation · doi:10.3727/096368911x612530 · Cited by 82
Stem cells combined with bone graft substitutes in skeletal tissue engineering
Gamie, Z., Tran, G. T., Vyzas, G., Korres, N., Heliotis, M., Mantalaris, A., & Tsiridis, E. E. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.679652 · Cited by 86
“The differentiation potential and lifespan of bone marrow-derived MSCs decrease with donor age, limiting their wide application [22,90,91].”
BackgroundCipriani, S., Bonini, D., Marchina, E., Balgkouranidou, I., Caimi, L., Zucconi, G. G., & Barlati, S. (2007) · Cell Biology International · doi:10.1016/j.cellbi.2007.01.037 · Cited by 86
Shevchenko, E. K., Макаревич, П. И., Цоколаева, З. И., Boldyreva, M. A., Sysoeva, V., Va, T., & Parfyonova, Y. V. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-138 · Cited by 84
“5 × 10(6) adipose stromal cells can be isolated from 1 ml of adipose tissue [29,30].”
BackgroundGibbs, N. J., Diamond, R., Sekyere, E. O., & Thomas, W. D. (2015) · Journal of Pain Research · doi:10.2147/jpr.s92090 · Cited by 81
Acceleration of Diabetic Wound Regeneration using an In Situ–Formed Stem‐Cell‐Based Skin Substitute
Dong, Y., Rodrigues, M., Kwon, S. H., Li, X., Sigen, A., Brett, E. A., Elvassore, N., Wang, W., & Gurtner, G. C. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800432 · Cited by 82
Secretome of Mesenchymal Stem Cells and Its Potential Protective Effects on Brain Pathologies
Báez-Jurado, E., Hidalgo‐Lanussa, O., Barrera-Bailón, B., Sahebkar, A., Ashraf, G. M., Echeverría, V., & Barreto, G. E. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1570-x · Cited by 87
Mesenchymal Stem Cells in Tissue Engineering
Leo, A. J., & Grande, D. A. (2006) · Cells Tissues Organs · doi:10.1159/000095985 · Cited by 91
“…2000; Asakura et al., 2001; Young et al., 2001; Huard et al., 2003], fat [Zuk et al., 2001; Mizuno, 2003; Wickham et al., 2003; Dicker et al., 2005; Kern et al., 2006], synovial tissue [De Bari et al., 2001], dermis [Young et al., 2001], adult peripheral blood [Zvaifler et al., 2000], and cord…”
BackgroundRogers, I. M., Yamanaka, N., Bielecki, R., Wong, C. J., Chua, S. J., Yuen, S., & Casper, R. F. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.02.029 · Cited by 88
“Although there have been reports of multi-potential mesenchymal cells in UCB (CD45neg cells) these cells are found infrequently [ 47 ,48].”
BackgroundChao, Y., Peng, C., Harn, H., Chan, C.-K., & Wu, K. (2010) · Annals of Hematology · doi:10.1007/s00277-009-0892-6 · Cited by 82
“It is of interest that cord blood MSCs exhibit higher proliferation capacity than bone marrow MSCs in vitro culture [22].”
BackgroundLiang, C., Li, H., Tao, Y., Peng, L., Gao, J.-Q., Wu, J., Li, F., Hua, J., & Chen, Q. (2013) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.08.019 · Cited by 82
Debnath, T., Ghosh, S., Shalini, U., Kona, L. K., Kamaraju, S. R., Sarkar, S., Gaddam, S., & Chelluri, L. K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120803 · Cited by 82
“Furthermore, our data is consistent with the population doubling values reported for stem cells derived from human adipose aspirates and marrow-derived stem cells [36].”
ResultSachs, P. C., Francis, M. P., Zhao, M., Brumelle, J., Rao, R. R., Elmore, L. W., & Holt, S. E. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1423-7 · Cited by 87
“…cells down multiple mesenchymal lineages as reported previously (Izadpanah et al. 2006; Zuk et al. 2001; Astori et al. 2007; Katz et al. 2005; Kern et al. 2006; Leong et al. 2005; Lin et al. 2008a, b; Noël et al. 2008; Rebelatto et al. 2008; Wagner et al. 2005; Yoshimura et al. 2006; Zhu et…”
BackgroundMethodResultInfluentialZhang, S.-C., Chen, L., Liu, T., Zhang, B., Xiang, D., Wang, Z., & Wang, Y. (2012) · Tissue Engineering Part A · doi:10.1089/ten.tea.2011.0516 · Cited by 82
“MSCs with hepatogenic capacities have also been isolated from umbilical cord blood,(8) but the yield of isolated cells is highly dependent in blood quality and remains limited compared with bone marrow.(12) Recently, several studies have focused on human umbilical cord matrix stem cells (hUCMSCs) as a novel source wit…”
BackgroundFaroni, A., Smith, R. J. P., Lu, L., & Reid, A. J. (2015) · European Journal of Neuroscience · doi:10.1111/ejn.13055 · Cited by 86
“…potential (Shimizu et al., 2007); however, adipose-derived stem cells (ASCs) have emerged as a more likely source for clinical use, owing to the ease of harvesting, a 500-fold greater yield, greater proliferation rates, and their immune-privileged potential (Zuk et al., 2001; Kern et al., 2006).”
BackgroundHuang, N. F., Lam, A., Fang, Q., Sievers, R. E., Song, L., & Lee, R. J. (2009) · Regenerative Medicine · doi:10.2217/rme.09.32 · Cited by 84
Osteoporosis and the Potential of Cell-Based Therapeutic Strategies
Macías, I., Alcorta-Sevillano, N., Rodríguez, C. I., & Infante, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051653 · Cited by 82
“Similar effects were obtained when BM-MSCs were injected in goats with long-term estrogen deficiency (mimicking the postmenopausal osteoporosis that occurs in humans) [148].”
BackgroundInfluentialBehbahan, I. S., Duan, Y., Lam, A., Khoobyari, S., Ma, X., Ahuja, T. P., & Zern, M. A. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-010-9216-4 · Cited by 78
“Hepatocytes-like cells have previously been derived from embryonic stem cells (ESC), bone marrow stem cells, adipose tissue, and mesenchymal cells, as well as multipotent progenitor cells in the human umbilical cord [4–10].”
BackgroundLam, A. T., Reuveny, S., & Oh, S. (2020) · Stem Cell Research · doi:10.1016/j.scr.2020.101738 · Cited by 80
Harn, H.-J., Lin, S.-Z., Hung, S.-H., Subeq, Y.-M., Li, Y.-S., Syu, W.-S., Ding, D.-C., Lee, R.-P., Hsieh, D.-K., Lin, P.-C., et al. (2012) · Cell Transplantation · doi:10.3727/096368912x652959 · Cited by 78
Hu, J., Wei, X., Zhao, W., Liu, Y., & Chen, G. (2008) · Acta Biomaterialia · doi:10.1016/j.actbio.2008.09.021 · Cited by 79
“Studies involving a variety of animal models have shown that MSCs could be useful in the repair or regeneration of damaged bone, cartilage or myocardial tissues, and are an attractive stem cell source for the regeneration of damaged tissues in clinical applications [30–32].”
BackgroundMethodKim, Y., & Broxmeyer, H. E. (2010) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2010.07.009 · Cited by 84
“Mesenchymal stem cells, also called mesenchymal stroma cells, were identified as undifferentiated stromal cells [128-129] originally from BM, and then from various other tissue sources [130].”
BackgroundInfluentialRyu, J. M., Lee, M. Y., Yun, S. P., & Han, H. J. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22091 · Cited by 80
Vériter, S., André, W., Aouassar, N., Poirel, H. A., Lafosse, A., Docquier, P.-L., & Dufrane, D. (2015) · PLOS ONE · doi:10.1371/journal.pone.0139566 · Cited by 78
“Adipose tissue-derived stem cells showed properties similar to those of bone marrow-derived MSCs and showed even better isolation reproducibility and higher proliferation capacity [12,13].”
BackgroundMesenchymal Stem Cells for the Treatment of Liver Disease: Present and Perspectives
Kang, S. H., Kim, M. Y., Eom, Y. W., & Baik, S. K. (2020) · Gut and Liver · doi:10.5009/gnl18412 · Cited by 78
“from these three sources are well-known to express similar surface antigens, whereas their morphology and proliferation rate vary.(13) First, although BM is the largest source, BM-derived MSCs may have restricted clinical use because of the invasive procedure required for their isolation, insufficient cell number, and…”
BackgroundTyeb, S., Shiekh, P. A., Verma, V., & Kumar, A. (2019) · Biomacromolecules · doi:10.1021/acs.biomac.9b01355 · Cited by 80
Cell Sources for Cartilage Repair—Biological and Clinical Perspective
Urlić, I., & Ivković, A. (2021) · Cells · doi:10.3390/cells10092496 · Cited by 82
“They have been compared to MSCs from other sources (BMMSCs and AD-BMCs), and their isolation success rate was significantly lower, but their proliferation capacity was the highest.”
BackgroundLiu, X., Peng, W., Wang, Y., Zhu, M., Sun, T., Peng, Q., Zeng, Y., Feng, B., Lu, X., Weng, J., et al. (2013) · Journal of Materials Chemistry B · doi:10.1039/c3tb20552e · Cited by 78
Adipose-Derived Mesenchymal Stem Cells: Are They a Good Therapeutic Strategy for Osteoarthritis?
Damiá, E., Chicharro, D., López, S., Cuervo, B., Rubio, M., Sopena, J. J., Vilar, J. M., & Carrillo, J. M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071926 · Cited by 81
Klontzas, M. E., Reakasame, S., Silva, R., Morais, J. C. F., Vernardis, S., MacFarlane, R. J., Heliotis, M., Tsiridis, E., Panoskaltsis, N., Boccaccini, A. R., et al. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.02.017 · Cited by 77
Translating Research into Clinical Scale Manufacturing of Mesenchymal Stromal Cells
Bieback, K., Kinzebach, S., & Karagianni, M. (2010) · Stem Cells International · doi:10.4061/2010/193519 · Cited by 80
“Adipose tissue (AT), most often obtained as lipoaspirate, has emerged as an alternative tissue because cells occur at high frequency and the procurement is less invasive than that of BM aspiration [2].”
BackgroundInfluentialSelf-citationHopf, A., Schaefer, D. J., Kalbermatten, D. F., Guzman, R. G., & Madduri, S. (2020) · Cells · doi:10.3390/cells9091990 · Cited by 82
Hydrogels for Large-Scale Expansion of Stem Cells
Yin, S., & Cao, Y. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.03.026 · Cited by 83
Mesenchymal stem cells isolated from peripheral blood and umbilical cord Wharton’s jelly
Trivanović, D. I., Kocić, J., Mojsilović, S. B., Krstić, J., Ilić, V. L., Djordjević, I. O., Santibanez, J. F., Jovčić, G., Terzić, M., & Bugarski, D. S. (2013) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh1304178t · Cited by 77
“The clonogenic capacities of MSCs derived from these two sources also differed, as UC-MSCs possessed 2-fold higher colony forming efficiency, similar to previous reports demonstrating higher proliferation capacities of neonatal tissue-derived MSCs in comparison to the adult tissue-derived MSCs [15,16, 17].”
MethodResultZhang, H., Liu, Z.-L., Yao, X.-Q., Yang, Z., & Xu, R. (2012) · Cytotherapy · doi:10.3109/14653249.2012.711470 · Cited by 84
Vossmerbaeumer, U., Ohnesorge, S., Kuehl, S., Haapalahti, M., Klüter, H., Jonas, J. B., Thierse, H., & Bieback, K. (2009) · Cytotherapy · doi:10.1080/14653240802714819 · Cited by 77
Self-citationA Comparative Analysis of Cartilage Engineered from Different Perinatal Mesenchymal Progenitor Cells
Kunisaki, S. M., Fuchs, J. R., Steigman, S. A., & Fauza, D. O. (2007) · Tissue Engineering · doi:10.1089/ten.2006.0407 · Cited by 80
“Nevertheless, this finding is consistent with those reported by others using human CB-derived MPCs. 24,25 In spite of the many similarities among the different MPCs analyzed, we found that AF-based MPCs proliferated more than twice as quickly in culture than BM-and CB-derived MPCs grown under…”
Ponnaiyan, D., & Jegadeesan, V. (2014) · European Journal of Dentistry · doi:10.4103/1305-7456.137631 · Cited by 77
“BM was obtained during cardiac surgery and obtained as described elsewhere.[9] The puncture site for BM aspiration at the sternum was located in the sternal midline.”
MethodKim, D. S., Lee, M. W., Yoo, K. H., Lee, T.-H., Kim, H. J., Jang, I. K., Chun, Y. H., Kim, H. J., Park, S. J., Lee, S. H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0083363 · Cited by 73
“CXC chemokine genes, including CXCL1, CXCL2, CXCL5, CXCL6, CXCL8 (IL8) and CXCL16, are up-regulated in CC2 MSCs; these factors mediate angiogenic activity [31] as well as survival, proliferation and chemotaxis of endothelial cells and activated T cells via autocrine and paracrine signaling mechanisms [10,11,22, 23,32,…”
BackgroundIn vitro immunologic properties of human umbilical cord perivascular cells
Ennis, J., Gotherstrom, C. O. T., Blanc, K. L., & Davies, J. E. (2008) · Cytotherapy · doi:10.1080/14653240801891667 · Cited by 84
Mesenchymal Stromal Cell Migration: Possibilities to Improve Cellular Therapy
Maijenburg, M. W., van der Schoot, C. E., & Voermans, C. (2011) · Stem Cells and Development · doi:10.1089/scd.2011.0270 · Cited by 81
“They can be obtained from almost every postnatal organ [6,7], including adipose tissue [8,9], the periosteum [10], brain [11], liver [6], skeletal muscle [11], hair follicles [12], peripheral blood [13], umbilical cord blood [14], and Wharton’s Jelly [15] as well as fetal tissues [16–18].”
Metadata
- Authors
- Kern, S., Eichler, H., Stoeve, J., Klüter, H., & Bieback, K.
- Affiliations
- German Red Cross (DE)
- Department of Orthopaedic Surgery of the University Hospital Mannheim, University of Heidelberg, Faculty of Clinical Medicine, Mannheim, Germany
- Corresponding author
- Bieback, Karen
- Venue
- STEM CELLS
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-05
- Volume
- 24
- Issue
- 5
- Pages
- 1294-1301
- ISSN
- 1066-5099 (ISSN-L)
- 1549-4918
- OpenAlex
- W2036348189
- Cited by
- 3,370
- References
- 37
- Citations by year
- 2026: 57 · 2025: 97 · 2024: 142 · 2023: 136 · 2022: 176 · 2021: 201 · 2020: 225 · 2019: 197 · 2018: 190 · 2017: 193 · 2016: 208 · 2015: 218 · 2014: 225 · 2013: 242 · 2012: 213
- FWCI
- 49.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- onlinelibrary.wiley.com/termsAndConditions#vor (vor)
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
- Locations
- Stem Cells (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Keywords
- mesenchymal stem cells, bone marrow, umbilical cord blood, adipose tissue, stem cell isolation, adipogenesis, multilineage differentiation, immunophenotype, stem cell expansion, cell therapy
- MeSH terms
- Adipose Tissue, Aged, Aged, 80 and over, Antigens, Surface, Bone Marrow Cells, Cell Differentiation, Cells, Cultured, Fetal Blood, Humans, Osteogenesis, Immunophenotyping, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.